Tirzepatide: A dual-agonist that targets two pathways (GLP-1 and GIP)
While Ozempic itself is not directly nephrotoxic, dehydration from GI side effects can stress kidneys that may already have reduced reserve capacity
At present, there are no large, randomised studies that directly compare the effects of these two drugs on overall survival rate
(Detailed dosing schedule will be provided with purchase) Dosing Schedule: Tirzepatide 2.5mg w/ Glycine and B12 (4 Injections) Tirzepatide 5mg w/ Glycine and B12 (4 Injections) Tirzepatide 7.5mg w/ Glycine and B12 (4 Injections) Tirzepatide 10mg w/ Glycine and B12 (4 Injections) Tirzepatide 12.5mg w/ Glycine and B12 (4 Injections) Tirzepatide 15mg w/ Glycine and B12 (4 Injections) Diet and Exercise Healthy eating and activity are recommended
Patients with history of pancreatitis should discuss risks carefully with healthcare providers
Wegovy is indicated for people ages 12 years and older who have: A BMI of 30 kg/m 2 or higher A BMI of 27 kg/m 2 to 29.9 kg/m 2 and at least one weight-related comorbidity , such as high blood pressure, type 2 diabetes, or obstructive sleep apnea Wegovy is also indicated to reduce the risk of major cardiovascular events , such as heart attack or stroke, in people who have obesity or overweight